UK markets closed
  • FTSE 100

    7,389.98
    +87.24 (+1.19%)
     
  • FTSE 250

    19,835.95
    +146.93 (+0.75%)
     
  • AIM

    956.64
    +9.47 (+1.00%)
     
  • GBP/EUR

    1.1822
    +0.0040 (+0.34%)
     
  • GBP/USD

    1.2495
    +0.0020 (+0.16%)
     
  • BTC-GBP

    23,518.87
    -16.31 (-0.07%)
     
  • CMC Crypto 200

    650.34
    -23.03 (-3.42%)
     
  • S&P 500

    3,901.36
    +0.57 (+0.01%)
     
  • DOW

    31,261.90
    +8.77 (+0.03%)
     
  • CRUDE OIL

    110.35
    +0.46 (+0.42%)
     
  • GOLD FUTURES

    1,845.10
    +3.90 (+0.21%)
     
  • NIKKEI 225

    26,739.03
    +336.19 (+1.27%)
     
  • HANG SENG

    20,717.24
    +596.56 (+2.96%)
     
  • DAX

    13,981.91
    +99.61 (+0.72%)
     
  • CAC 40

    6,285.24
    +12.53 (+0.20%)
     

Hydrocephalus Market Industry Forecast Report 2022, Featuring Profiles of Aesculap, Integra Lifesciences, Karl Storz, Proteses, Medtronic and Natus Medical

·5-min read
Company Logo
Company Logo

Global Hydrocephalus Market

Global Hydrocephalus Market
Global Hydrocephalus Market

Dublin, May 09, 2022 (GLOBE NEWSWIRE) -- The "Hydrocephalus Market by Cause, Type, Diagnosis, Treatment and Age: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.

The global hydrocephalus market was valued at $6907.5 million in 2020 and is projected to reach $10178.6 million by 2030, registering a CAGR of 4.0% from 2021 to 2030.

One of the prominent factors responsible for the growth in the hydrocephalus market includes the increase in the number of hydrocephalic patients, which subsequently leads to the increase in the number of shunting procedures across the world. For instance, according to the hydrocephalus association, in 2021, over 36,000 shunt surgeries are performed each year (one every 15 minutes) and more than half of them represent emergencies.

Moreover, high demand for neurosurgery devices & accessories for hydrocephalus management and a rise in cases of neurological disorders, owing to congenital abnormalities and lifestyle diseases as well as a rise in incidences of brain and nerve injuries, boosts the demand for hydrocephalic shunts.

Furthermore, the key developmental strategies such as product approval, partnership, and launch of various novel hydrocephalic valves by key players are further projected to propel the growth of the market. For instance, in 2021, Anuncia Inc., an emerging leader in Cerebral Spinal Fluid (CSF) management, received U.S. Food and Drug Administration (FDA) breakthrough device designation for its ReFlow System Mini intended for the treatment of CSF disorders requiring shunting such as hydrocephalus.

Furthermore, in 2020, Aesculap, Inc., in partnership with the Christoph Miethke GmbH & Co. KG (MIETHKE), announced the launch of the M.blue valve, the latest generation of Hydrocephalus valve technology. Its unique gravitational technology is integrated with a fixed differential pressure unit in one valve, allowing for a simple, position-dependent solution. These strategies are certainly enhancing the company's footprints in the Hydrocephalus market, thereby contributing to the overall growth of the market.

However, serious damages caused by infections and malfunctions of existing shunts greatly limit the market growth. Some deleterious complications include irreversible brain injuries, meningitis, endocarditis, traumatic perforation, tricuspid regurgitation, heart failure, pulmonary hypertension, and others. For instance, according to the Hydrocephalus Association, approximately 50% of shunts in the pediatric population fail within two years of placement, requiring repeated neurological operations. On the contrary, advancements in shunt technology for reducing shunt complications are projected to create lucrative opportunities for market growth.

The hydrocephalus market is segmented on the basis of cause, type, diagnosis, treatment, age and region. On the basis of cause, the market is categorized into congenital hydrocephalus and acquired hydrocephalus. By type, the market is segmented into communicating hydrocephalus and non-communicating hydrocephalus. The communicating hydrocephalus is categorized into normal pressure hydrocephalus, ex-vacuo hydrocephalus. The diagnosis segment is fragmented into CT scan, MRI, and ultrasound. Furthermore, on the basis of treatment, the market is categorized into surgery shunt insertion and ventriculostomy.

The age is categorized into Neonate & Pediatrics and Adults. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key report benefits:

  • The study provides an in-depth analysis of the global hydrocephalus market along with the current trends and future estimations to elucidate the imminent investment pockets.

  • A comprehensive analysis of the factors that drive and restrict market growth is provided in the report.

  • A comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.

  • Extensive analysis of the key segments of the industry helps understand the different types of hydrocephalus across the globe.

  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

Key Topics Covered:

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.3. Porter's five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Growth in prevalence of hydrocephalus
3.4.1.2. Surge in adoption of hydrocephalus shunt
3.4.1.3. Increase in incidences of neurological disorders
3.4.2. Restraint
3.4.2.1. Shunt malfunction and related infections
3.4.3. Opportunity
3.4.3.1. Advancements in technology in the healthcare sector
3.5. Top player positioning
3.6. Communicating hydrocephalus: Causes, Symptoms, and Treatments
3.7. COVID-19 Impact on the market

CHAPTER 4: HYDROCEPHALUS MARKET, BY CAUSE
4.1. Overview
4.2. Congenital Hydrocephalus
4.3. Acquired hydrocephalus

CHAPTER 5: HYDROCEPHALUS MARKET, BY TYPE
5.1. Overview
5.2. Communicating hydrocephalus
5.3. Non-communicating hydrocephalus

CHAPTER 6: HYDROCEPHALUS MARKET, BY DIAGNOSIS
6.1. Overview
6.2. CT Scan
6.3. MRI
6.4. Ultrasound

CHAPTER 7: HYDROCEPHALUS MARKET, BY TREATMENT
7.1. Overview
7.2. Surgery shunt insertion
7.3. Ventriculostomy

CHAPTER 8: HYDROCEPHALUS MARKET, BY AGE
8.1. Overview
8.2. Neonate and Pediatrics
8.3. Adults

CHAPTER 9: HYDROCEPHALUS MARKET, BY REGION

CHAPTER 10: COMPANY PROFILES

  • Aesculap Inc.

  • Integra Lifesciences

  • Karl Storz SE and Co. Kg

  • Proteses Inc.

  • Medtronic Plc

  • Natus Medical Inc.

CHAPTER 11: COMPANY PROFILES: SERVICE BASED

  • Boston Children's Hospital

  • Anadolu Medical Center

  • Helios Hospital

  • Texas Children's Hospital

  • Children's National Hospital

For more information about this report visit https://www.researchandmarkets.com/r/p3coge

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting